These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28835081)

  • 1. [The clinicopathological features and risk factors of recurrence in patients with mucinous borderline ovarian tumors].
    Sun L; Song Y; Li N; Yuan GW; Sun YC; Li N; Ma SK; Zhang X; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):589-594. PubMed ID: 28835081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics.
    Song T; Choi CH; Lee YY; Kim TJ; Lee JW; Sung CO; Song SY; Bae DS; Kim BG
    Gynecol Obstet Invest; 2013; 76(4):241-7. PubMed ID: 24192519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline Ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
    Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
    Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
    Saygili U; Uslu T; Erten O; Doğan E
    Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.
    Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Int J Gynecol Cancer; 2012 Jun; 22(5):770-7. PubMed ID: 22426410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.
    Dewilde K; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Gynecol Obstet Invest; 2018; 83(1):65-69. PubMed ID: 28689208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis?
    Song T; Lee DH; Jung YW; Yun BS; Seong SJ; Choi CH; Lee JW; Bae DS; Kim BG
    Gynecol Obstet Invest; 2018; 83(1):45-51. PubMed ID: 28571024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
    Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
    Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma.
    He X; Ying R; Jia L; Li Y; Li R
    Gland Surg; 2023 Apr; 12(4):453-464. PubMed ID: 37200926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor.
    Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
    J Int Med Res; 2019 Jan; 47(1):96-104. PubMed ID: 30198356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous carcinoma of the ovary. Clinicopathologic analysis.
    Kikkawa F; Kawai M; Tamakoshi K; Suganuma N; Nakashima N; Furuhashi Y; Kuzuya K; Hattori S; Arii Y; Tomoda Y
    Oncology; 1996; 53(4):303-7. PubMed ID: 8692534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
    Rodríguez IM; Prat J
    Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
    Lu YY; Guo AT; Liu AJ; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies.
    Lorusso D; Ratti M; Ditto A; Raspagliesi F
    Oncology; 2014; 87(3):183-92. PubMed ID: 25033912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
    Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
    Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent intestinal mucinous borderline tumors of the ovary: a report of 5 cases causing problems in diagnosis, including distinction from mucinous carcinoma.
    Irving JA; Clement PB
    Int J Gynecol Pathol; 2014 Mar; 33(2):156-65. PubMed ID: 24487471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.